Sitemap   Print Eng 繁體
  • ABOUT CK LIFE SCIENCES
    1. Corporate Profile
    2. Board of Directors
    3. Board Committees
    4. Corporate Governance Policies
  • CORE BUSINESSES
    1. Agriculture-related Business
    2. Nutraceutical Business
    3. Pharmaceuticals & Diagnostics R&D
  • INVESTOR RELATIONS
    1. 2026 Annual General Meeting
    2. Legal Announcements
    3. Shareholder Information
    4. Dissemination of Corporate Communications
    5. Annual & Interim Reports
    6. Corporate Information
    7. Stock Information
    8. Risk Factors
  • SUSTAINABILITY
    1. Sustainability Policies
    2. Sustainability Committee
    3. Sustainability Report
  • CAREERS
  • CONTACT US
  • 2026 AGM

2026 Annual General Meeting

Home > Investor Relations > 2026 Annual General Meeting

  • 2026 Annual General Meeting
    1. Notification Letter to Registered Holder (2026 AGM)
    2. Proxy Form for AGM
    3. Notice of AGM
    4. Circular (Election of Directors, Remuneration of Directors and Board Committee Members, General Mandates to Issue & Buy Back Shares & Notice of AGM)
    5. Online User Guide for the AGM
  • Legal Announcements
  • Shareholder Information
  • Dissemination of Corporate Communications
  • Annual & Interim Reports
  • Corporate Information
  • Stock Information
  • Risk Factors

Webcast – CKLS 2026 Annual General Meeting (21 May 2026)

  • 2026
  • 12 May 2026

    Online User Guide for the AGM

  • 17 Apr 2026

    Notification Letter to Registered Holder (2026 AGM)

  • 17 Apr 2026

    Proxy Form for AGM

  • 17 Apr 2026

    Notice of AGM

  • 17 Apr 2026

    Circular (Election of Directors, Remuneration of Directors and Board Committee Members, General Mandates to Issue & Buy Back Shares & Notice of AGM)

Copyright © 2026 CK Life Sciences Int’l., (Holdings) Inc. All rights reserved. Disclaimer Privacy Policy